Chong Kun Dang Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Chong Kun Dang Holdings Stock Forecast and Price Target
Given the average yearlong price target of ₩63000.00 provided by prominent analysts over the past few months, there is a potential upside of approximately 1.61% from the last closing price in May, 2024 for Chong Kun Dang Holdings's stock if it is reached. This estimation is based on a high estimate of ₩63000.00 and a low estimate of ₩63000.00. If you're looking for Chong Kun Dang Holdings (A001630) stock information, you might also want to check out Sam Chun Dang Pharm. (KOSDAQ:A000250).
1.61% Upside
Chong Kun Dang Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Chong Kun Dang Holdings's Price has gone down from ₩154.12k to ₩0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Chong Kun Dang Holdings will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩317.00k | Buy/Sell | ₩382.71k | 32.49% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩116.60k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩201.00k | Buy/Sell | ₩201.75k | 8.96% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩35.25k | Buy/Sell | ₩44.67k | 27.66% |
Chong Kun Dang Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Revenue for Chong Kun Dang Holdings has grown by 5.93%, going from ₩858.12B to ₩908.96B. In the next year, 0 analysts estimate that Chong Kun Dang Holdings's Revenue will decrease by 1.20%, reaching ₩898.09B. According to professional forecasts, in 2030, Chong Kun Dang Holdings's Revenue will decrease by 1.15%, reaching ₩898.53B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩101.90k | Buy/Sell | ₩124.29k | 47.20% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩111.90k | Buy/Sell | ₩156.10k | 42.98% |
.jpg)
Chong Kun Dang Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Chong Kun Dang Holdings's Dividend per Share has fallen from ₩1400.00 to ₩1400.00 – a 0.00% decrease. According to 0 analysts, Chong Kun Dang Holdings's Dividend per Share will fall by 0.00% in the next year, reaching ₩1400.00. Professionals believe that By 2030, Chong Kun Dang Holdings's Dividend per Share will fall to ₩1400.00 – a 0.00% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.77k | Buy/Sell | ₩38.00k | 33.19% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩11.07k | Buy/Sell | ₩13.50k | 44.53% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.99k | Buy/Sell | ₩20.00k | 41.26% |
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩30.35k | Buy/Sell | ₩40.62k | 38.39% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
Chong Kun Dang Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Chong Kun Dang Holdings's EBITDA has decreased by 91.57%, going from ₩119.40B to ₩10.06B. For next year, the 0 analysts predict EBITDA of ₩52.48B, which would mean an increase of 421.39%. Over the next eight years, the pros' prediction is EBITDAof ₩250.66B, which would mean a eight-year growth forecast of 2390.54%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩64.80k | Buy/Sell | ₩74.50k | 25.77% |
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
Chong Kun Dang Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Chong Kun Dang Holdings's EBIT has decreased from ₩89.05B to ₩-32.88B – a 136.92% drop. In the next year, analysts expect EBIT to reach ₩-95.14B – an increase of 189.37%. For the next eight years, the forecast is for EBIT to grow by 433.96%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩30.85k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.35k | Buy/Sell | ₩17.66k | -100.00% |
Chong Kun Dang Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Chong Kun Dang Holdings's EPS has gone down from ₩15.71k to ₩0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Chong Kun Dang Holdings will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩15.43k | Buy/Sell | ₩23.00k | 62.02% |
| A053030 Stock Forecast | BINEX | - |
16
|
₩13.43k | Buy/Sell | ₩18.00k | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
Site Navigation
.jpg)